T2 Biosystems Inc EBIT margin
Quel est le EBIT margin de T2 Biosystems Inc?
Le EBIT margin de T2 Biosystems Inc est -618.72%
Quelle est la définition de EBIT margin?
EBIT margin is a profitability ratio that measures earnings of the company as a percentage of revenue without taking into account the effect of taxes and interest.
ttm (trailing twelve months)
EBIT margin measures the profitability and operational efficiency of a company. It compares the amount of money that remains after the cost of goods and all operating expenses are subtracted from net revenue to sales. EBIT margin is calculated as earnings before interest and taxes divided by net revenue.
EBIT and EBIT margin evaluate how well a business manages its operations. Interest and taxes are not operating expenses and don’t impact operating efficiency. EBIT margin is usually used to compare operational efficiency and profitability of companies within the same industry. Taxes can vary by location thus excluding them from the calculation gives a better basis for comparing different companies.
EBIT and operating income are often used interchangeably, but there is a difference between them, which can cause the numbers to give different results. The key difference is that operating income does not include non-operating income, non-operating expenses, and other income.
EBIT margin des entreprises dans Health Care secteur sur NASDAQ par rapport à T2 Biosystems Inc
Que fait T2 Biosystems Inc?
t2 biosystems is developing innovative diagnostic products to improve patient health. with two fda-cleared products targeting sepsis – the cause of one out of two hospital deaths - and a range of additional products in development, t2 biosystems is an emerging leader in the field of in vitro diagnostics. our initial development efforts target sepsis, hemostasis, bacteria and lyme disease, which are areas of significant unmet medical need. the company is utilizing its proprietary t2 magnetic resonance platform, or t2mr®, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. at t2 biosystems, we know that our passion to advance the medical diagnostic landscape relies on our ability to attract and retain the very best people in the world – and to encourage them to flourish. we invite you to apply for one of our open positions at www
Entreprises avec ebit margin similaire à T2 Biosystems Inc
- The Good Shroom Co a EBIT margin de -623.66%
- Valeura a EBIT margin de -623.64%
- Ocugen Inc a EBIT margin de -620.91%
- BioCardia a EBIT margin de -620.06%
- BioCardia a EBIT margin de -620.06%
- BioCardia a EBIT margin de -620.06%
- T2 Biosystems Inc a EBIT margin de -618.72%
- Neuropathix a EBIT margin de -618.48%
- Relief Therapeutics AG a EBIT margin de -612.68%
- Fisker a EBIT margin de -611.79%
- PLx Pharma a EBIT margin de -610.30%
- Phivida a EBIT margin de -603.01%
- Compagnie du Cambodge a EBIT margin de -600.00%